Nursing home operators not only beat their goal of 15% reduction of long-stay residents receiving antipsychotic medications, they soared to an 18.8% cutback, according to the Centers for Medicare & Medicaid Services.
The agency’s most recent figures showed that 19.4% of long-stay residents were taking antipsychotics, down from a baseline mark of 23.9% at the end of 2011.
Among states doing the best with reductions is Hawaii, while Texas is among the worst.
New goals for reductions of 25% by 2016 and 30% by 2017 were set in September.
From the December 01, 2014 Issue of McKnight's Long-Term Care News